Literature DB >> 22824478

Mechanisms of simple hepatic steatosis: not so simple after all.

Scott C Matherly1, Puneet Puri.   

Abstract

Nonalcoholic fatty liver disease is becoming an epidemic. Fat is typically stored in adipose tissue in the form of triglycerides (TGs). The deposition of TGs in the liver is the result of an imbalance between the amount of energy taken in and the amount used. This balance is maintained by a complex interplay between the dietary intake of nutrients, the hormonal response to the nutrients, and their effect on both the liver and adipose tissue. Disruption of this system is what leads to the development of steatosis and is the focus of this article.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22824478     DOI: 10.1016/j.cld.2012.05.005

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  12 in total

1.  Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis.

Authors:  Caroline C Duwaerts; Jacquelyn J Maher
Journal:  Curr Hepatol Rep       Date:  2014-06-01

Review 2.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

3.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy; Kelli A Lytle
Journal:  Proc Nutr Soc       Date:  2015-08-18       Impact factor: 6.297

Review 4.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy; Kelli A Lytle
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

Review 5.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

Review 6.  Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy.

Authors:  Qing-Qing Zhang; Lun-Gen Lu
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

7.  In Vitro Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay.

Authors:  Hui Fan; Yuan-Yuan Chen; Wei-Jian Bei; Lai-You Wang; Bao-Tian Chen; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-18       Impact factor: 2.629

Review 8.  The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background.

Authors:  Jinsheng Yu; Sharon Marsh; Junbo Hu; Wenke Feng; Chaodong Wu
Journal:  Gastroenterol Res Pract       Date:  2016-05-09       Impact factor: 2.260

9.  Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.

Authors:  Bubu A Banini; Arun J Sanyal
Journal:  Clin Med Insights Ther       Date:  2016-12-18

10.  Sex Difference in the Association between Serum Homocysteine Level and Non-Alcoholic Fatty Liver Disease.

Authors:  Bo-Youn Won; Kyung-Chae Park; Soo-Hyun Lee; Sung-Hwan Yun; Moon-Jong Kim; Kye-Seon Park; Young-Sang Kim; Ji-Hee Haam; Hyung-Yuk Kim; Hye-Jung Kim; Ki-Hyun Park
Journal:  Korean J Fam Med       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.